A krónikus antikoaguláns-kezelés gyakorlati kérdései Covid-19-pandémia idején

Komócsi, András

Coronavirus infection has a multiple im - pact on the coagulation system and anti - coagulant therapies. Patients admitted with COVID-19 have un - usually high incidence of coagulation ab - normalities. The incidence of atrial fibrillation (AF) seems also to be more frequent among COVID-19 out- and especially inpatients. Among COVID-19 patients receiving oral anticoagulant therapy, for minimizing the risk of bleeding or thromboembolic complications there should also be considered the renal and hepatic functions and drugdrug interactions of oral anticoagulant and COVID-19 therapy. In case of direct anticoagulants, in addition to the benefits of better safety, more favorable treatment ad - he rence, and fixed dosing, the use of this class of drugs does not require laboratory mo nitoring of efficacy, which may be of exp licit benefit in terms of social distancing and health network burdens. This study reviews the possible interactions of drugs used for viral infection and anticoagulation, and in addition to the issues of coagulopathy associated with COVID-19, we discuss also the concerning difficulties of continued anticoagulant therapy related to the social distancing measures. © 2021 Literatura Medica Publishing House. All rights reserved.